Hypoxia-Induced Activation of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3′-Kinase Signaling Pathways Contributes to Expression of Interleukin 8 in Human Ovarian Carcinoma Cells

Clinical Cancer Research

Volumn 10, Issue 2, 2004, Pages 701-707

  Xu, Lei ^a   Pathak, Pooja S ^a   Fukumura, Dai ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; NORTHERN BLOTTING; ONCOGENE RAS; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANOXIA; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, DOMINANT; GENES, REPORTER; HUMANS; INTERLEUKIN-8; LUCIFERASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0842311598     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0953-03     Document Type: Article

References (41)

1. Matsushima, K., and Oppenheim, J. J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine, 1: 2-13, 1989.
2. Peveri, P., Walz, A., Dewald, B., and Baggiolini, M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med., 167: 1547-1559, 1988.
3. Miyamoto, M., Shimizu, Y., Okada, K., Kashii, Y., Higuchi, K., and Watanabe, A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol. Immunother., 47: 47-57, 1998.
4. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Wash. DC), 258: 1798-1801, 1992.
5. Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., and Bar-Eli, M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
6. Yatsunami, J., Tsuruta, N., Ogata, K., Wakamatsu, K., Takayama, K., Kawasaki, M., Nakanishi, Y., Hara, N., and Hayashi, S. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett., 120: 101-108, 1997.
7. Brew, R., Erikson, J. S., West, D. C., Kinselia, A. R., Slavin, J., and Christmas, S. E. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine, 12: 78-85, 2000.
8. Xu, L., and Fidler, I. J. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res., 60: 4610-4616, 2000.
9. Coleman, C. N., Mitchell, J. B., and Camphausen, K. Tumor hypoxia: chicken, egg, or a piece of the farm? J. Clin. Oncol., 20: 610-615, 2002.
10. Xu, L., Xie, K., Mukaida, N., Matsushima, K., and Fidler, I. J. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res., 59: 5822-5829, 1999.
11. Mukaida, N., Okamoto, S., Ishikawa, Y., and Matsushima, K. Molecular mechanism of interleukin-8 gene expression. J. Leukocyte Biol., 56: 554-558, 1994.
12. Karin, M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene, 22: 6867-6874, 1999.
13. Reddy, S. A., Huang, J. H., and Liao, W. S. Phosphatidylinositol 3-kinase in interleukin 1 signaling: physical interaction with the interleukin 1 receptor and requirement in NFκβ and AP-1 activation. J. Biol. Chem., 272: 29167-29173, 1997.
14. Pan, Z. K., Christiansen, S. C., Ptasznik, A., and Zuraw, B. L. Requirement of phosphatidylinositol 3-kinase activity for bradykinin stimulation of NF-κβ activation in cultured human epithelial cells. J. Biol. Chem., 274: 9918-9922, 1999.
15. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., and Donner, D. B. NF-κβ activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (Lond.), 401: 82-85, 1999.
16. Romashkova, J. A., and Makarov, S. S. NF-κβ is a target of AKT in anti-apoptotic PDGF signalling. Nature (Lond.), 401: 86-90, 1999.
17. Sizemore, N., Leung, S., and Stark, G. R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κβ p65/RelA subunit. Mol. Cell. Biol., 19: 4798-4805, 1999.
18. Treisman, R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol., 8: 205-215, 1996.
19. Kallunki, T., Deng, T., Hibi, M., and Karin, M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell, 87: 929-939, 1996.
20. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45: 3668-3676, 1985.
21. Alvarez-Tejado, M., Naranjo-Suarez, S., Jimenez, C., Carrera, A. C., Landazuri, M. O., and del Peso, L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem., 276: 22368-22374, 2001.
22. Chen, E. Y., Mazure, N. M., Cooper, J. A., and Giaccia, A. J. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res., 61: 2429-2433, 2001.
23. Arici, A., Oral, E., Bukulmez, O., Buradagunta, S., Engin, O., and Olive, D. L. Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells. Endocrinology, 137: 3762-3769, 1996.
24. Yoneda, J., Kuniyasu, H., Crispens, M. A., Price, J. E., Bucana, C. D., and Fidler, I. J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. (Bethesda), 90: 447-454, 1998.
25. Herrera, C. A., Xu, L., Bucana, C. D., Silva el, V. G., Hess, K. R., Gershenson, D. M., and Fidler, I. J. Expression of metastasis-related genes in human epithelial ovarian tumors. Int. J. Oncol., 20: 5-13, 2002.
26. Karakurum, M., Shreeniwas, R., Chen, J., Pinsky, D., Yan, S. D., Anderson, M., Sunouchi, K., Major, J., Hamilton, T., Kuwabara, K., et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Investig., 93: 1564-1570, 1994.
27. Desbaillets, I., Diserens, A. C., Tribolet, N., Hamou, M. F., and Van Meir, E. G. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med., 186: 1201-1212, 1997.
28. Conrad, P. W., Rust, R. T., Han, J., Millhorn, D. E., and Beitner-Johnson, D. Selective activation of p38α and p38γ by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J. Biol. Chem., 274: 23570-23576, 1999.
29. Kulisz, A., Chen, N., Chandel, N. S., Shao, Z., and Schumacker, P. T. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am. J. Physiol. Lung Cell Mol. Physiol., 282: L1324-L1329, 2002.
30. Stancovski, I., and Baltimore, D. NF-κβ activation: the Iκβ kinase revealed? Cell, 91: 299-302, 1997.
31. Baeuerle, P. A., and Baltimore, D. NF-κβ: ten years after. Cell, 87: 13-20, 1996.
32. Bird, T. A., Schooley, K., Dower, S. K., Hagen, H., and Virca, G. D. Activation of nuclear transcription factor NF-κβ by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem., 272: 32606-32612, 1997.
33. 2 sensing. J. Biol. Chem., 275: 25130-25138, 2000.
34. Mazure, N. M., Chen, E. Y., Laderoute, K. R., and Giaccia, A. J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood, 90: 3322-3331, 1997.
35. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
36. Pacold, M. E., Suire, S., Perisic, O., Lara-Gonzalez, S., Davis, C. T., Walker, E. H., Hawkins, P. T., Stephens, L., Eccleston, J. F., and Williams, R. L. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase γ. Cell, 103: 931-943, 2000.
37. Schmedtje, J. F., Jr., Liu, W. L., Ji, Y., Thompson, T. M., and Runge, M. S. Evidence of hypoxia-inducible factor-1 in vascular endothelial and smooth muscle cells. Biochem. Biophys. Res. Commun., 220: 687-691, 1996.
38. Semenza, G. L., Nejfelt, M. K., Chi, S. M., and Antonarakis, S. E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, 88: 5680-5684, 1991.
39. Kvietikova, I., Wenger, R. H., Marti, H. H., and Gassmann, M. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res., 23: 4542-4550, 1995.
40. Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., and Livingston, D. M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA, 93: 12969-12973, 1996.
41. Lee, T. H., Avraham, H., Lee, S. H., and Avraham, S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem., 277: 10445-10451, 2002.